FOUNDAYO 5.5 mg Tablets – 30s

FOUNDAYO 5.5 mg Tablets – 30s (Orforglipron)

Once-Daily Oral GLP-1 Medicine for Chronic Weight Management

FOUNDAYO 5.5 mg contains orforglipron, an oral GLP-1 receptor agonist prescribed for chronic weight management in eligible adults with obesity or overweight with weight-related health conditions. It is used together with a reduced-calorie diet and increased physical activity.

Why Choose FOUNDAYO 5.5 mg?

✔ Oral GLP-1 Treatment – Convenient tablet formulation with no injection required.
✔ Supports Weight Management – Helps reduce and maintain body weight when combined with diet and physical activity.
✔ Once-Daily Tablet – Designed for convenient daily administration.
✔ Part of Dose Escalation – 5.5 mg is generally reached after the 0.8 mg and 2.5 mg stages, according to the prescribed titration schedule.
✔ Pack Size: 30 tablets.

Active Ingredient

● Orforglipron 5.5 mg per tablet – a small-molecule GLP-1 receptor agonist.

How to Use

Take FOUNDAYO exactly as prescribed by your doctor. The dose should not be started, increased, or changed without medical advice.

Important: FOUNDAYO is a prescription medicine. Common adverse effects can include nausea, diarrhea, constipation, vomiting, indigestion, and abdominal discomfort. Please consult a doctor or pharmacist before use.

🛒 Available from PharmaCare – Online Pharmacy Qatar